23 May 2013
Keywords: cubist, cubicin, available, usa, pharmaceuticals, launched, its
Article | 10 November 2003
Cubist Pharmaceuticals has launched its Cubicin (daptomycin forinjection) in the USA. This follows approval by the US Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 October 2003
22 September 2003
22 May 2013
© 2013 thepharmaletter.com